Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pausing E-Health Record Meaningful Use Incentives Would Stall Progress, HHS Official Says

This article was originally published in The Pink Sheet Daily

Executive Summary

Any pause in the current electronic health record meaningful use incentive program could stall momentum on EHR adoption, HHS National Coordinator for Health IT Mostashari tells the Senate Finance Committee.

You may also be interested in...



HHS Seeks Suggestions On Hastening E-Health Record Interoperability, Data Exchange

Hinting that the electronic health record incentive program is not resulting in quick-enough adoption of interoperable systems, HHS asks for suggestions on how to speed up the process of making EHRs interoperable, as well as to get providers to utilize health information exchange.

CMS Finalizes Stage 2 Standards For Electronic Health Records With Delayed Implementation

Agency gives eligible physicians and hospitals that started earning incentive payments for the meaningful use of electronic health records in 2011 an additional year, until 2014, to begin demonstrating that they are meeting the standards outlined in the recently finalized rule.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS075976

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel